Medcamp

Medcamp Financing Cash Flow

The Net Financing Cash Flow of Medcamp (MDP.WA) as of Nov 6, 2026 is 90.00 PLN. In the previous year, Net Financing Cash Flow was 38,870.00 PLN — a change of -99.77% (lower).

Financing Cash Flow

90.00PLN

YoY

-99.77%

Last updated:

Net Financing Cash Flow of Medcamp is 2020 90.00 PLN. Net Financing Cash Flow of Medcamp was 2019 38,870.00 PLN. It decreases by -99.77% lower compared to the previous year.

The Medcamp Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2014
40,000.00 PLN
Jan 1, 2015
464,300.00 PLN
Jan 1, 2016
45,460.00 PLN
Jan 1, 2017
-159,920.00 PLN
Jan 1, 2018
73,530.00 PLN
Jan 1, 2019
38,870.00 PLN
Jan 1, 2020
90.00 PLN
The Medcamp Financing Cash Flow history
YEARFinancing Cash FlowYoY
90.00PLN-99.77%
38,870.00PLN-47.14%
73,530.00PLN-145.98%
-159,920.00PLN-451.78%
45,460.00PLN-90.21%
464,300.00PLN+1,060.75%
40,000.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medcamp Stock analysis

What does Medcamp do? MEDCAMP SA generates revenue through research and development services in biotechnology, focusing on personalized medicine, genetics, genomics, and bioinformatics supported by artificial intelligence. The company manages and develops commercial properties such as office areas and warehouses in locations including Poznan, Jasielska; Poznan, Komorniki; Poznan, Jasielska, Inkubator; and Szamotuly, Dworcowa, offering rental and sale services. Long-term investments in construction and real estate entities, alongside property acquisition and redevelopment, contribute to its revenue streams. Subsidiaries like T2 Inkubator Sp z o o, T2 Szamotuly Sp z o o, and Polskie Centrum Badan i Rozwoju Sp z o o support these operations. The primary buyers of MEDCAMP SA's services and properties include entities seeking research and development facilities in biotechnology, particularly those interested in AI-driven solutions for personalized medicine. Commercial tenants and real estate investors are key customers for the rental and sale of office and warehouse spaces. The company's focus on building a research and development center in Poznan attracts specialized clients in the biotech sector, while its property management projects target long-term investors in real estate development. MEDCAMP SA's revenue model combines biotech R&D services with real estate operations, leveraging its subsidiaries to manage diverse property portfolios. The firm's strategic focus on AI-supported biotechnology research positions it to serve clients in emerging fields, while its property management activities cater to commercial and investment markets. The majority shareholder Moonrock Enterprise SA provides strategic oversight, aligning the company's operations with broader investment goals. Medcamp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medcamp stock

Net Financing Cash Flow of Medcamp is 90.00 PLN in 2020.

Net Financing Cash Flow of Medcamp changed from 38,870.00 PLN to 90.00 PLN, representing a -99.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Medcamp since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Medcamp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Medcamp

All Key Metrics — Medcamp